Back to Companies
Kyverna Therapeutics, Inc.
KYTXNasdaqCIK: 0001994702
Over the 9 most recent insider filings, Kyverna Therapeutics, Inc. (KYTX) has seen activity from 7 distinct insiders — 2 buying and 1 selling. The activity is heavily weighted toward buying: $2.0M bought versus $292.8K sold, a net purchase of $1.7M. Shaw Christi is the most active by dollar volume, and the single largest transaction was $1.5M by Shaw Christi. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$4.8M
Purchases
$2.0M
Sales
$292.8K
Unique Insiders
7
Recent Insider Trades
9 loaded
| May 29 | KYTX Kyverna Therapeutics, Inc. | Shaw Christi | Insider | Tax withheld | $36.0K |
| May 29 | KYTX Kyverna Therapeutics, Inc. | SEIDENBERG BETH C | Insider | Grant | $176.8K |
| May 29 | KYTX Kyverna Therapeutics, Inc. | CLARK IAN T | Insider | Grant | $176.8K |
| May 29 | KYTX Kyverna Therapeutics, Inc. | Cohen Fred E | Insider | Grant | $176.8K |
| May 29 | KYTX Kyverna Therapeutics, Inc. | Aktar Mert | Insider | Grant | $176.8K |
| Jan 14 | KYTX Kyverna Therapeutics, Inc. | Shaw Christi | Insider | Grant | $1.5M |
| Dec 22 | KYTX Kyverna Therapeutics, Inc. | SEIDENBERG BETH C | Director | Buy | $1000.0K |
| Dec 22 | KYTX Kyverna Therapeutics, Inc. | Westlake BioPartners Opportunity Fund I, L.P. | 10% Owner | Buy | $1000.0K |
| Dec 17 | KYTX Kyverna Therapeutics, Inc. | Walker Karen Marie | Insider | Sell | $292.8K |
9 filings